PEX-17719-38232 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-20
Registered in v-safe
2020-12-20
Dose 1 — Pfizer-BioNTech
2020-12-20
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · Nausea

Adult check-in
2020-12-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-27
Survey response — day 7, dose 1
MedDRA: Oropharyngeal pain — Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness

Free text: Sore throat

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-03
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-10
Dose 2 — Pfizer-BioNTech
2021-01-10
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-01-11
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-01-11
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-12
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness, Diarrhea

Adult check-in
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Diarrhea

Adult check-in
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Diarrhea

Adult check-in
2021-01-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-17
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-24
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-01-31
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-07
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-16
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-02-21
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-11
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-13
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-12-18
Dose 3 — Pfizer-BioNTech
2021-12-19
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-12-20
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-12-21
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-12-22
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Free text: Swollen lymph nodes

MedDRA releases: 2024-11 · check-in free text available
2021-12-23
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-12-24
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-12-28
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2022-01-01
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-01-08
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-01-15
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-01-24
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-01-31
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-03-21
Health check-in — 3 months, dose 3
Feeling: Fair

Adult check-in
2022-12-18
Survey response — 12 months, dose 3
MedDRA: Influenza, Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: I've had RSV and Influenza A

MedDRA releases: 2024-11 · check-in free text available
2022-12-18
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-12-20
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-20	Pfizer-BioNTech
2	2021-01-10	Pfizer-BioNTech
3	2021-12-18	Pfizer-BioNTech	No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 1 — day 7, dose 1

2020-12-27

Systemic reaction (other): Sore throat

Release 10 — days 1–6 daily, dose 3

2021-12-22

Systemic reaction (other): Swollen lymph nodes

Release 12 — 12 months, dose 3

2022-12-18

Symptoms: I've had RSV and Influenza A

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Influenza	·	·	✓
SD	Respiratory syncytial virus infection	·	·	✓
SRO	Lymphadenopathy	·	·	✓
SRO	Oropharyngeal pain	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release